Ruben Smith - Concepedia

Author

Ruben Smith

Also Known As

Andrea Sharma, Dimitri Van De Ville, Emma Pettersson, Ingmar Skoog, Lars-Olof Wahlund, Luz Gibbons, Neil P. Oxtoby, Niklas Mattsson-Carlgren, Phyllis Wingo, R Smith

284

Publications

16.6K

Citations

H-Index

141

Concepts

All Affiliations

Lund University Skåne University Hospital Amsterdam Neuroscience University of Gothenburg Centers for Disease Control and Prevention

About

Ruben Smith is an author at Lund University specializing in medicine, neuroscience, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	3.6K
2	Public Health	12	15	856
3	Health Sciences	5	5	129
4	Natural Sciences	1	1	132
5	Nursing	1	1	49

Ruben Smith

116

Publications

13.8K

Citations

H-Index

Page 1

	Year	Citations
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders Sebastian Palmqvist, Shorena Janelidze, Yakeel T. Quiroz, JAMA	2020	1.4K
Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Nature Medicine Neurodegenerative DiseasesPlasma P-tau181Alzheimer's DiseaseAgingLongitudinal Progression	2020	1.2K
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease Joana B. Pereira, Shorena Janelidze, Ruben Smith, Brain	2021	532
The Pregnancy Risk Assessment Monitoring System (PRAMS): Overview of Design and Methodology Holly B. Shulman, Denise V. D’Angelo, Leslie Harrison, American Journal of Public Health FertilityReproductive HealthGynecologyReproductive EpidemiologyData System	2018	530
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease Jacob W. Vogel, Yasser Iturria‐Medina, Olof Strandberg, Nature Communications Neurochemical BiomarkersSynaptic SignalingSocial SciencesTau SpreadAlzheimer's Disease	2020	509
Discriminative Accuracy of [<sup>18</sup>F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders Rik Ossenkoppele, Gil D. Rabinovici, Ruben Smith, JAMA	2018	459
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, Nature Medicine	2022	446
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease Shorena Janelidze, Erik Stomrud, Ruben Smith, Nature Communications	2020	437
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease Shorena Janelidze, David Berron, Ruben Smith, JAMA Neurology	2020	355
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease Niklas Mattsson, Emelie Andersson, Shorena Janelidze, Science Advances	2020	347

Page 1